Jump to: Page Content, Site Navigation, Site Search,
You are seeing this message because your web browser does not support basic web standards. Find out more about why this message is appearing and what you can do to make your experience on this site better.
BMJ 2003;327:E261 (4 October), doi:10.1136/bmjusa.01070007 (published 5 September 2002)
This article originally appeared in BMJ USA
A two year follow up of 447 Finnish hospital doctors and their
senior nurse controls has found that the doctors took about one third
of the amount of sick leave taken by their controls. But there were no
differences in health outcomes, self rated health status, and the
prevalence of chronic illness between the two groups
(
Occupational and Environmental Medicine 2001;58:361-366
Jet lag may prove more harmful than just making us feel groggy. Researchers from Bristol University used structural magnetic resonance imaging to show that airline workers with several years' experience of disrupted circadian rhythms have smaller temporal lobes than those who have notched up similar flight times on domestic routes ( Nature Neuroscience 2001;4:567-568[CrossRef][ISI][Medline]). They also had chronically higher cortisol levels, which have previously been correlated with smaller temporal lobes and memory impairment. The same may be true for shift workers.
Minerva fortunately lives in an overheated home and rarely
suffers coughs and colds. Her experience is borne out by a study of
more than 10 000 Finnish students (
Thorax 2001;56:462-467
Doctors are beginning to realise that COX 2 inhibitors such as rofecoxib (Vioxx) and celecoxib (Celebrex), which their developers claim cause fewer ulcers than other analgesics, are not all they're cracked up to be. Data presented to the US Food and Drug Administration suggest that patients taking these drugs have a higher risk of heart attacks than patients taking older pain relievers (about four heart attacks per 1000 patients). According to The New York Times (22 May), the Food and Drug Administration is considering adding cardiovascular warnings to the drug labels.
The case for breast screening programmes is now beyond debate. A meticulous report from Sweden covering almost 30 years of screening shows that the overall impact is impressive: 63% reduction in breast cancer deaths in women screened. According to a commentator in the May issue of ( Cancer 2001;91:1699-1703[CrossRef][ISI][Medline]), concerns about false positive and false negative results should be put into perspective and considered secondary to the major public health breakthrough that breast screening has achieved.
Another debate, this time about whether coffee and tea
consumption raises the risk of urinary tract cancer, appears in the
(
International Journal of Epidemiology 2001;30:353-361
Little is known about the long term outcome of using proton pump
inhibitors to treat gastro-oesophageal reflux. A follow up of a
prospective randomised trial of medical and surgical anti-reflux
treatment reported in
JAMA 2001;285:2331-2338
Black patients with heart failure have a poorer prognosis than
their white counterparts. To see if racial differences in response to
drug treatment account for this, 1196 white patients were matched with
800 black patients from the studies of left ventricular dysfunction
(SOLVD) trials. Researchers observed a 44% reduction in hospital
admissions for heart failure in white patients taking enalapril
compared with placebo. No significant reduction was seen among the
black cohort (
New England Journal of Medicine 2001;344:1351-1357
|
Getting smokers with heart disease to take the risks of smoking
seriously can be frustrating. So it's a relief to read that a hospital
based prevention and rehabilitation programme for all patients
presenting for the first time with coronary artery disease seems to
have achieved wonders (
Heart 2001;85:533-538
Sex drive depends on several factors, and problems can arise when one partner has a higher libido than the other. According to a preliminary, single blind study of 51 women with unexplained low libido, one solution may lie in Zyban (bupropion), the antidepressant more commonly taken in the USA to help people stop smoking ( Journal of Sex and Marital Therapy 2001;27:303-316). After eight weeks, almost 30% of the women taking the drug reported an improvement in their sex drive. Minerva wonders if this could be women's answer to sildenafil.
![]()
CiteULike
Complore
Connotea
Del.icio.us
Digg
Reddit
Technorati What's this?
Israeli students are refusing to perform intimate examinations on anaesthetised women without their informed consent.